Verona Pharma PLC Q2 2023 Earnings Call Transcript - Thomson StreetEvents

Verona Pharma PLC Q2 2023 Earnings Call Transcript

Verona Pharma PLC Q2 2023 Earnings Call Transcript - Thomson StreetEvents
Verona Pharma PLC Q2 2023 Earnings Call Transcript
Published Aug 03, 2023
11 pages (6322 words) — Published Aug 03, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of VRNA.OQ earnings conference call or presentation 3-Aug-23 1:00pm GMT

  
Brief Excerpt:

...Operator Welcome to Verona Pharma Second Quarter 2023 Financial Results and Operating Highlights Conference Call. (Operator Instructions) Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3-months ended on June 30, 2023. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com. Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements. These forward-looking statements are based on the management's current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause the actual results, performance and achievements to be materially different from the expectations expressed [in implanting for] forward-looking statements. Any such forward-looking statements represent management existing on the date...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Verona Pharma PLC
Ticker
VRNA.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Andreas Argyrides - Wedbush Securities Inc., Research Division - Analyst : Congrats on all the progress as well. Just two from us to start here, what additional analyses from ENHANCE can we expect to see at ERS and CHEST? And then can you provide any updates on where you stand with the combination product of ensifentrine and LAMA? Is there a certain amount that you think will work best in conjunction with that suspension? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 03, 2023 / 1:00PM, VRNA.OQ - Q2 2023 Verona Pharma PLC Earnings Call

Table Of Contents

Verona Pharma PLC OhtuvayreTM FDA Approval Conference Call and Webcast Transcript – 2024-06-27 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 27-Jun-24 12:30pm GMT

Verona Pharma PLC at JPMorgan Healthcare Conference Transcript – 2024-01-11 – US$ 54.00 – Edited Transcript of VRNA.OQ presentation 11-Jan-24 12:30am GMT

Verona Pharma PLC Q3 2023 Earnings Call Transcript – 2023-11-02 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 2-Nov-23 1:00pm GMT

Verona Pharma PLC Investor Launch Update Transcript – 2023-10-18 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 18-Oct-23 12:00pm GMT

Verona Pharma PLC at Canaccord Genuity Growth Conference Transcript – 2023-08-09 – US$ 54.00 – Edited Transcript of VRNA.OQ presentation 9-Aug-23 4:00pm GMT

Verona Pharma PLC at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of VRNA.OQ presentation 7-Jun-23 12:00pm GMT

Verona Pharma PLC To Discuss The Phase 3 ENHANCE Data Presented At ATS 2023 Transcript – 2023-05-23 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 23-May-23 8:00pm GMT

Verona Pharma PLC Q1 2023 Earnings Call Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-May-23 1:00pm GMT

Full Year 2022 Verona Pharma PLC Earnings Call Transcript – 2023-03-07 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 7-Mar-23 2:00pm GMT

Verona Pharma PLC Corporate Call Transcript – 2022-12-20 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 20-Dec-22 8:30am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Verona Pharma PLC Q2 2023 Earnings Call Transcript" Aug 03, 2023. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Verona-Pharma-PLC-Earnings-Call-T15665394>
  
APA:
Thomson StreetEvents. (2023). Verona Pharma PLC Q2 2023 Earnings Call Transcript Aug 03, 2023. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Verona-Pharma-PLC-Earnings-Call-T15665394>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.